Financhill
Back

Enfusion Quote, Financials, Valuation and Earnings

Enfusion Price Quote

$10.64
+0.01 (+1.62%)
(Updated: December 21, 2024 at 5:24 AM ET)

Enfusion Key Stats

Buy
72
Enfusion (ENFN) is a Buy

Day range:
$10.22 - $10.74
52-week range:
$7.52 - $11.38
Dividend yield:
0%
P/E ratio:
151.86
P/S ratio:
6.47
P/B ratio:
14.35%

Volume:
935.2K
Avg. volume:
519.8K
1-year change:
10.16%
Market cap:
$1B
Revenue:
$174.5M
EPS:
$0.04

How Much Does Enfusion Make?

Data Unavailable

Is Enfusion Growing As A Company?

Data Unavailable

Enfusion Stock Price Performance

  • Did Enfusion Stock Go Up Last Month?
    Enfusion share price went up by 7.48% last month
  • Did ENFN's Share Price Rise Over The Last Year?
    ENFN share price rose by 10.16% over the past 1 year

What Is Enfusion 52-Week High & Low?

  • What Is Enfusion’s 52-Week High Share Price?
    Enfusion has traded as high as $11.38 over the past 52 weeks
  • What Is Enfusion’s 52-Week Low Share Price?
    Enfusion has traded as low as $7.52 over the past 52 weeks

Enfusion Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Enfusion?

Data Unavailable

Is Enfusion Cash Flow Positive?

Data Unavailable

Enfusion Return On Invested Capital

Data Unavailable

Enfusion Earnings Date & Stock Price

  • What Is Enfusion's Stock Price Today?
    A single share of ENFN can be purchased today for 10.63
  • What Is Enfusion’s Stock Symbol?
    Enfusion trades on the nyse under the ticker symbol: ENFN
  • When Is Enfusion’s Next Earnings Date?
    The next quarterly earnings date for Enfusion is scheduled on March 12, 2025
  • When Is ENFN's next ex-dividend date?
    Enfusion's next ex-dividend date is December 22, 2024
  • How To Buy Enfusion Stock?
    You can buy Enfusion shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Enfusion Competitors

  • Who Are Enfusion's Competitors?
    Below is a list of companies who compete with Enfusion or are related in some way:
    • BM Technologies Inc (BMTX)
    • Castellum Inc (CTM)
    • DigitalOcean Holdings Inc (DOCN)
    • F5 Inc (FFIV)
    • Klaviyo Inc (KVYO)

Enfusion Dividend Yield

Data Unavailable

Enfusion Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -11.88%
Revenue: 15.35% -1.92%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable